Evaluation of pharmacogenetic markers to predict the risk of Cisplatin-induced ototoxicity

doi:10.1038/clpt.2014.67

Comment

. 2014 Aug;96(2):156-7.

doi: 10.1038/clpt.2014.67. Epub 2014 Mar 18.

Evaluation of pharmacogenetic markers to predict the risk of Cisplatin-induced ototoxicity

C Lanvers-Kaminsky¹, I Malath¹, D Deuster², G Ciarimboli³, J Boos¹, A G Am Zehnhoff-Dinnesen⁴

Affiliations

¹ Department of Pediatric Hematology and Oncology, University Children's Hospital of Muenster, Muenster, Germany.
² Department of Phoniatrics and Pedaudiology, University Hospital of Muenster, Muenster, Germany.
³ 1] Experimental Nephrology, Department of Internal Medicine D, University Hospital of Muenster, Muenster, Germany [2] Interdisciplinary Center for Clinical Research, University Hospital of Muenster, Muenster, Germany.
⁴ 1] Department of Phoniatrics and Pedaudiology, University Hospital of Muenster, Muenster, Germany [2] Interdisciplinary Center for Clinical Research, University Hospital of Muenster, Muenster, Germany.

PMID: 24642735
DOI: 10.1038/clpt.2014.67

Comment

Evaluation of pharmacogenetic markers to predict the risk of Cisplatin-induced ototoxicity

C Lanvers-Kaminsky et al. Clin Pharmacol Ther. 2014 Aug.

. 2014 Aug;96(2):156-7.

doi: 10.1038/clpt.2014.67. Epub 2014 Mar 18.

Authors

C Lanvers-Kaminsky¹, I Malath¹, D Deuster², G Ciarimboli³, J Boos¹, A G Am Zehnhoff-Dinnesen⁴

Affiliations

¹ Department of Pediatric Hematology and Oncology, University Children's Hospital of Muenster, Muenster, Germany.
² Department of Phoniatrics and Pedaudiology, University Hospital of Muenster, Muenster, Germany.
³ 1] Experimental Nephrology, Department of Internal Medicine D, University Hospital of Muenster, Muenster, Germany [2] Interdisciplinary Center for Clinical Research, University Hospital of Muenster, Muenster, Germany.
⁴ 1] Department of Phoniatrics and Pedaudiology, University Hospital of Muenster, Muenster, Germany [2] Interdisciplinary Center for Clinical Research, University Hospital of Muenster, Muenster, Germany.

PMID: 24642735
DOI: 10.1038/clpt.2014.67

No abstract available

PubMed Disclaimer

Comment in

Response to "evaluation of pharmacogenetic markers to predict the risk of Cisplatin-induced ototoxicity".
Carleton BC, Ross CJ, Bhavsar AP, Lee JW, Visscher H, Rassekh SR, Hayden MR. Carleton BC, et al. Clin Pharmacol Ther. 2014 Aug;96(2):158. doi: 10.1038/clpt.2014.90. Epub 2014 Apr 22. Clin Pharmacol Ther. 2014. PMID: 24755913 No abstract available.

Comment on

Replication of TPMT and ABCC3 genetic variants highly associated with cisplatin-induced hearing loss in children.
Pussegoda K, Ross CJ, Visscher H, Yazdanpanah M, Brooks B, Rassekh SR, Zada YF, Dubé MP, Carleton BC, Hayden MR; CPNDS Consortium. Pussegoda K, et al. Clin Pharmacol Ther. 2013 Aug;94(2):243-51. doi: 10.1038/clpt.2013.80. Epub 2013 Apr 10. Clin Pharmacol Ther. 2013. PMID: 23588304 Free PMC article.
The role of inherited TPMT and COMT genetic variation in cisplatin-induced ototoxicity in children with cancer.
Yang JJ, Lim JY, Huang J, Bass J, Wu J, Wang C, Fang J, Stewart E, Harstead EH, E S, Robinson GW, Evans WE, Pappo A, Zuo J, Relling MV, Onar-Thomas A, Gajjar A, Stewart CF. Yang JJ, et al. Clin Pharmacol Ther. 2013 Aug;94(2):252-9. doi: 10.1038/clpt.2013.121. Epub 2013 Jun 11. Clin Pharmacol Ther. 2013. PMID: 23820299 Free PMC article.
Genetics of cisplatin ototoxicity: confirming the unexplained?
Boddy AV. Boddy AV. Clin Pharmacol Ther. 2013 Aug;94(2):198-200. doi: 10.1038/clpt.2013.116. Clin Pharmacol Ther. 2013. PMID: 23872836

Cited by

Agonists and Inhibitors of the cGAS-STING Pathway.
Yu X, Cai L, Yao J, Li C, Wang X. Yu X, et al. Molecules. 2024 Jun 30;29(13):3121. doi: 10.3390/molecules29133121. Molecules. 2024. PMID: 38999073 Free PMC article. Review.
TPMT, COMT and ACYP2 genetic variants in paediatric cancer patients with cisplatin-induced ototoxicity.
Thiesen S, Yin P, Jorgensen AL, Zhang JE, Manzo V, McEvoy L, Barton C, Picton S, Bailey S, Brock P, Vyas H, Walker D, Makin G, Bandi S, Pizer B, Hawcutt DB, Pirmohamed M. Thiesen S, et al. Pharmacogenet Genomics. 2017 Jun;27(6):213-222. doi: 10.1097/FPC.0000000000000281. Pharmacogenet Genomics. 2017. PMID: 28445188 Free PMC article.
Pharmacogenomics in Pediatric Patients: Towards Personalized Medicine.
Maagdenberg H, Vijverberg SJ, Bierings MB, Carleton BC, Arets HG, de Boer A, Maitland-van der Zee AH. Maagdenberg H, et al. Paediatr Drugs. 2016 Aug;18(4):251-60. doi: 10.1007/s40272-016-0176-2. Paediatr Drugs. 2016. PMID: 27142473 Free PMC article. Review.
Common variants in ACYP2 influence susceptibility to cisplatin-induced hearing loss.
Xu H, Robinson GW, Huang J, Lim JY, Zhang H, Bass JK, Broniscer A, Chintagumpala M, Bartels U, Gururangan S, Hassall T, Fisher M, Cohn R, Yamashita T, Teitz T, Zuo J, Onar-Thomas A, Gajjar A, Stewart CF, Yang JJ. Xu H, et al. Nat Genet. 2015 Mar;47(3):263-6. doi: 10.1038/ng.3217. Epub 2015 Feb 9. Nat Genet. 2015. PMID: 25665007 Free PMC article.
Platinum-induced hearing loss after treatment for childhood cancer.
van As JW, van den Berg H, van Dalen EC. van As JW, et al. Cochrane Database Syst Rev. 2016 Aug 3;2016(8):CD010181. doi: 10.1002/14651858.CD010181.pub2. Cochrane Database Syst Rev. 2016. PMID: 27486906 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Wiley
Other Literature Sources
- The Lens - Patent Citations Database
- scite Smart Citations
Molecular Biology Databases
- Pharmacogenomics Knowledge Base

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Evaluation of pharmacogenetic markers to predict the risk of Cisplatin-induced ototoxicity

Affiliations

Evaluation of pharmacogenetic markers to predict the risk of Cisplatin-induced ototoxicity

Authors

Affiliations

Comment in

Comment on

Similar articles

Cited by

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Molecular Biology Databases

Comment in

Comment on

Similar articles

Cited by

Publication types

MeSH terms

Substances

Related information

LinkOut - more resources

Full Text Sources

Other Literature Sources

Molecular Biology Databases